A more complete listing of resources for professionals using second-generation antipsychotic medications in children is available
here. More information about how to refer a patient to the Mental Health Metabolic Program is available
here.

Information for parents and caregivers

The following handouts are designed to give to families of children or adolescents who will be starting or who are already using atypical antipsychotic medications:

A more complete listing of resources for parents and caregivers of children using second-generation antipsychotic medications is available
here. More information about the Mental Health Metabolic Program is available
here.

The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) Guideline Project of the Canadian Academy of Child and Adolescent Psychiatry have published
guidelines for monitoring for complications and safety of second-generation antipsychotics in chilldren and adolescents in Canada: